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Abstract
Background: Chromosomal imbalances, recognized as the major cause of mental retardation, are often due to
submicroscopic deletions or duplications not evidenced by conventional cytogenetic methods. To date, interstitial
deletion of long arm of chromosome 2 have been reported for more than 100 cases, although studies reporting
small interstitial deletions involving the 2q24.1q24.2 region are rare. With the widespread clinical use of
comparative genomic hybridization chromosomal microarray technology, several cryptic chromosome imbalances
have outlined new genotype-phenotype correlations and isolated a number of distinctive clinical conditions.
Results: here we report on a girl with mental retardation and generalized hypotonia. A genome-wide screen for
copy number variations (CNVs) using single nucleotide polymorphisms (SNPs) array revealed a 7.5 Mb interstitial
deletion of chromosome region 2q24.1q24.2 encompassing 59 genes, which was absent in parents. The gene
content analysis of the deleted region and review of the literature revealed the presence of some genes that may
be indicated as good candidate in generating the main clinical features of the patient.
Discussion: the present case represents a further patient described in the literature with an interstitial deletion of
chromosome 2q24.1q24.2. Our patient shares some clinical features with the previously reported patients carriers of
overlapping 2q24 deletion. Although more cases are needed to delineate the full-blown phenotype of 2q24.1q24.2
deletion syndrome, published data and present observation suggest that hemizygosity of this region results in a
clinically recognizable phenotype. Considering these clinical and cytogenetic similarities, we suggest the existence
of an emerging syndrome associated to 2q24.1q24.2 region.
Keywords: mental retardation, 2q24.1q24.2, array comparative genomic hybridization
Background
Conventional cytogenetic analysis have identified more
than 100 individuals with constitutional deletion within
2q. In particular, over 70 patients with a terminal deletion
and over 30 with an interstitial deletion have already been
reported [1,2]. Most of the examined patients presented a
mental retardation varying between severe and profound,
hypotonia and dysmorphic features. Phenotype variations
are likely to be due to differences in the size and location
of the segmental aneuploidy. The most frequent interstitial
deletion involves the cytogenetic bands 2q31q33 and cor-
responds to a specific phenotype [3,4]. Only few cases
showed overlapping deletions, although of quite different
extensions, and most of the reported cases with 2q inter-
stitial deletion have been detected with standard cytoge-
netic techniques showing poor definition of breakpoints.
Thus, genotype-phenotype correlations in cases with a 2q
deletion not involving 2q31q33 bands are more difficult.
With the advent of Array based comparative genomic
hybridization (array-CGH), the detection rate of submicro-
scopic chromosomal abnormalities have been improved
considerably. To our best knowledge, studies reporting
small interstitial deletions involving or partial overlapping
the 2q24.1q24.2 region are rare. Takatsuki et al. [5]
reported a patient with a deletion of 2q24.2q24.3 with
delayed growth, mental retardation, generalized hypotonia,
myoclonic seizures, and peculiar dysmorphic features,
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Magri et al. [6] reported a patient with severe mental
retardation, muscular hypotonia and characteristic dys-
morphic features, who carried a de novo 5.3 Mb deletion
in 2q24.2q24.3.
Moreover, in ECARUCA database was reported a
patient, ID 4547, carrying a deletion in 2q24.2 who pre-
sented mental retardation, hypotonia and joint laxity.
Here we describe a patient carrying a de novo intersti-
tial deletion of chromosome 2q24.1q24.2. Size and
breakpoint of the deletion were determinate through
SNP-Array analysis. A comparison of the clinical fea-
tures in the individual reported here to those of pre-
viously reported individuals, suggests that
haploinsufficiency of some genes encompassed by the
deletion could possibly be related to mental retardation
and hypotonia in patients with deletion of 2q24.1q24.2.
Finally, we further demonstrate the importance of the
use of array-CGH technology in clinical setting to per-
form genotype-phenotype correlation.
Case presentation
The Caucasian patient is the second child of a 42-years-
old mother and 43-years-old father. The parents were
healthy and non-consanguineous. Facial appearance was
normal. She was born after an uneventful pregnancy.
There was no family history of children born with conge-
nital disease, intellectual disability, autism, seizures, neuro-
logic disorders, metabolic disorder, recurrent pregnancy
loss or infertility. Birth weight was 2700 g (50°C), height
was 46,5 cm (< 3°C) and head circumference was 31 cm (<
3°C). Clinical examination revealed the presence of bilater-
ally hip dislocation. At 5 months of life the patient showed
generalized hypotonia that required hospitalization. Karyo-
type and genetic test for Wolf syndrome, Rett syndrome,
Spinal Muscular Atrophy, and Prader-Willi syndrome
resulted normal. She started to speech some words when
she was 3 years old. At that time her weight was 12,6 Kg
(25°C), height was 93 cm (50°C), and cranial circumference
48 cm (10°C). She began to show a marked bruxism at age
4 years. Several instrumental examinations were per-
formed in order to exclude the presence of other congeni-
tal malformation. Audiometric evaluation did not show
hearing impairment, cerebral magnetic resonance imaging
(MRI) did not reveal any alteration, cardiovascular,
respiratory and abdominal examinations were normal.
Metabolic studies including plasma amino acids, lac-
tate, glucose, transferring isoelectric-focusing, urine
organic acids, urine oligosaccharides were all normal.
Results
Conventional karyotyping by GTG banding at 550 bands
of resolution revealed an apparently normal female kar-
yotype of 46,XX.
Microarrays analysis was carried out using the Gene-
Chip Human Mapping 250 K NspI Array. This analysis
detected a 7.5 Mb deletion in the long arm of chromo-
some 2, from band 2q24.1 to band 2q24.2 (NCBI gen-
ome build 36). The breakpoint in band 2q24.1 was
located between the last present probe SNP_A-2022259
(155.413.315 bp) and the first deleted probe SNP_A-
4194091 (155.526.470 bp), while the breakpoint in band
2q24.2 was located between the last deleted probe
SNP_A-4234249 (163.058.894 bp) and the first present
probe SNP_A-1954343 (163.101.007 bp) (Figure 1).
The deletion was confirmed by a second experiment
of SNPs array using the GeneChip Human Mapping 250
K StyI Array. Array analysis of the parents showed no
abnormalities demonstrating a “de novo” origin of the
deletion in the patient (Figure 1).
Discussion
We present a case with a 7.5 Mb de novo deletion of
chromosome 2q24.1q24.2 encompassing 59 genes
detected by SNP array. Clinical features include mental
retardation, generalized hypotonia, marked bruxism and
bilaterally hip dislocation. A comparison of the clinical
features observed in our patient with the previously
reported cases identified by array comparative genomic
hybridization, that clearly overlap the current case,
shows several common features including mental retar-
dation and hypotonia. This deletion overlaps the dele-
tion recently reported by Takatsuki et al. and two other
patients: one described by Magri et al. and one reported
in ECARUCA database (ID 4547). Takatsuki et al.
described a patient with delayed growth, mental retarda-
tion, generalized hypotonia, myoclonic seizures, and
Figure 1 Results of Affymetrix 250 K NspI array.C o p yn u m b e r
state of each probe is drawn along chromosome 2 from
135.000.000 to 170.000.000 bp. The upper panel represents the copy
number state of the father, the middle panel the mother and the
lower panel the proband. Values of Y-axis indicate the inferred copy
number according to probe intensities.
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monary emphysema. In this paper, the ITGB6 gene was
indicated as responsible of the pulmonary phenotype
observed in the patient described. According to these
authors, the master genes responsible for myoclonic sei-
zures are SCN1A and SCN2A (two genes located outside
the boundaries of our deletion), while we are in agree-
ment with Magri et al. about the role of ITGB6. In fact,
despite the evidence that this gene was deleted in our
patient and in the patient reported by Magri et al., no
pulmonary diseases were recorded in his case history.
Although it would seem to be no evidence indicating a
strong relationship between haploinsufficiency of ITGB6
and pulmonary dysfunction, to indicate a defective pene-
trance or, alternatively, to suggest that additional genes
are requested in causing this peculiar clinical sign, we
suggest a clinical surveillance against pulmonary diseases
in patients with 2q deletions encompassing ITGB6.
The other two patients, one described by Magri et al.
and one reported in ECARUCA database (ID 4547), pre-
sented non-specific abnormalities such as mental retar-
dation, prenatal growth retardation and sever hypotonia.
The deleted region shared by all the patients (from
160.408.000 bp to 163.058.894 bp; hg 18) (Figure 2A)
contains 15 genes among which at least 5 candidate
genes (SLC4A10, TBR1, KCNH7, DPP4, GCG)c o u l db e
related to clinical features presented by our patient.
Copy number variants have not been detected in normal
individuals (Database of Human genomic variants,
http://projects.tcag.ca/variation accessed June 2011) for
these five genes (Figure 2B).
Solute carrier family 4, sodium bicarbonate transpor-
ter, member 10 (SLC4A10, MIM: 605556) belongs to a
small family of sodium-coupled bicarbonate transporters
(NCBTs) that regulate the intracellular pH of neurons,
the secretion of bicarbonate ions across the choroid
plexus, and the pH of the brain extracellular fluid. Dis-
ruption of sodium bicarbonate transporter SLC4A10 it
has also been associated with mental retardation and
epilepsy [7].
T - b o x ,b r a i n ,1( TBR1, MIM: 604616) is a member of
a conserved family of genes that share a common DNA-
binding domain, the T-box. T-box genes encode tran-
scription factors involved in the regulation of develop-
mental processes. A similar protein has been disrupted
in mice and shown to be critical for early cortical devel-
opment, and causes loss of projection neurons in the
olfactory bulbs and olfactory cortex [8].
Potassium voltage-gated channel, subfamily H (eag-
related), member 7 (KCNH7, MIM: 608169) encodes a
member of the potassium channel, voltage-gated, sub-
family H. This family of channels are characterized by
their anomalous gating behavior, with inactivation
kinetics being faster than activation kinetics and with
recovery from inactivation being faster than deactiva-
tion. Their diverse functions include regulating neuro-
transmitter release, heart rate, insulin secretion,
neuronal excitability, epithelial electrolyte transport,
smooth muscle contraction, and cell volume [9].
Since these genes have an important role in the brain,
their haploinsufficiency could possibly be related to
mental retardation and developmental delay in the
patients.
Mental retardation and hypotonia have been asso-
ciated in some cases with alteration in the carbohydrate
metabolism [6]. In particular, in the region 2q24 encom-
passed by the deletion, there are two genes (DPP4,
MIM: 102720; GCG, MIM: 138030) involved in carbohy-
drate metabolism.
Obviously, all suggested clinical features postulated to
relate to loss of one copy of a particular candidate gene
located inside the deleted region remain to be elucidated
by further gene expression studies either on experimen-
tal in vivo animal models or on diagnostic material.
In conclusion, we suggest that deletions of chromo-
some 2q24.1q24.2 could be associated to a specific
Figure 2 Screenshot of the deleted region. (A) Gene content of
the deleted regions based on UCSC Genome Browser. The black
boxes represent our case plus the patients reported by Magri et al.,
in ECARUCA database (ID 4547) and by Takatsuki et al. The red
arrow shows the critical region shared by the patients (B) Copy
number variations present in the deleted region based on Database
of Human genomic variants.
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lation cannot be drawn yet, due to the low number of
patients described and the large size of the deletions.
Future genotype-phenotype comparison studies with
more cases, along with gene expression studies, are
needed to define whether a one-gene haploinsufficiency
or more putative genes of the suggested critical regions
could be associated with each major clinical features of
2q24.1q24.2 deletion phenotype.
Materials and methods
SNP Array analysis
High molecular weight genomic DNA was extracted
from peripheral blood lymphocytes of the patient and
both his parents, according EZ1 Robot procedure (Qia-
gen, Valencia, CA). DNA concentration was determined
with NanoDrop ND-1000 spectrophotometer and soft-
ware (NanoDrop Technologies, Berlin, Germany), while
genome wide single nucleotide polymorphism (SNP)
array analysis was carried out using the GeneChip
Human Mapping 250 K NspI (Affymetrix, Santa Clara,
CA, USA), which contains 25-mer oligonucleotide repre-
senting a total of 262.264 SNPs with an average resolu-
tion of ~12 kb. An amount of 250 ng DNA was
processed according to the manufacturer’si n s t r u c t i o n s .
Briefly, total genomic DNA was digested with a restric-
tion enzyme (NspI), ligated to an appropriate adapter
for the enzyme, and subjected to PCR amplification
using a single primer. After digestion with DNase I, the
PCR products were labeled with a biotinylated nucleo-
tide analogue, using terminal deoxynucleotidyl transfer-
ase and hybridized to the microarray. The wash and
staining steps were performed using the Fluidic Station
450 and finally the array was scanned with the Gene-
Chip Scanner 7 G using Command Console Software
(Affymetrix, Santa Clara, CA, USA). Quality control
(QC) and copy number analysis was performed using
Genotyping Console Software 4.0 (Affymetrix, Santa
Clara, CA, USA). Briefly: i) the raw data files (.CEL)
were normalized using the default options; ii) an
unpaired analysis was perfomed using as baseline the
270 HapMap samples in order to obtain Copy numbers
value from .CEL files while the amplificated and/or
deleted region were detected using a standard Hidden
Markov Model (HMM) method.
Copy number changes identified in the samples were
visualized by using the UCSC Genome Browser website
http://genome.ucsc.edu and also compared to the Data-
base of Genomic Variants http://projects.tcag.ca/varia-
tion to exclude copy number changes considered as
benign variants. The DECIPHER https://decipher.sanger.
ac.uk/ and ECARUCA http://umcecaruca01.extern.
umcn.nl:8080/ecaruca/ecaruca.jsp databases were
expedient as resources to aid genotype-phenotype
correlation.
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